Skip to main content
. 2015 Apr;240(4):519–526. doi: 10.1177/1535370214549533

Figure 1.

Figure 1

IVF rates (2–4 cell embryo stage) of ovulated immature oocytes resulting from superovulated mice treated with 7.5 mg CLZ. (a) IVF rates of ovulated MI oocytes resulting from superovulated mice treated with 7.5 mg CLZ 7 h pre-hCG (Group I). (b) IVF rates of ovulated MI oocytes resulting from superovulated mice treated with 7.5 mg CLZ 4 h pre-hCG (Group II). (c) IVF rates of ovulated GV oocytes resulting from superovulated mice treated with 7.5 mg CLZ 4 h pre-hCG and 2 h post-hCG (Group III). Columns with different superscripts are significantly different (P < 0.02 for Figure 1(a), P < 0.002 for Figure 1(b), and P < 0.0001 for Figure 1(c)). Numbers inside columns represent the total number of used oocytes in each subgroup, and 12–16 mice were used in each subgroup